CAN
AKBA icon

Cetera Advisor Networks’s Akebia Therapeutics AKBA Stock Holding History

Cetera Advisor Networks’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-16,292
Closed -$221K – 1279
2020
Q2 		$221K Buy
+16,292
New +$169K 0.01% 1067

Other funds holding AKBA

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cetera Advisor Networks's AKBA Position: Q3 2020 in Review

Cetera Advisor Networks sold out of Akebia Therapeutics (AKBA) in Q3 2020, closing a stake of 16,292 shares — an estimated $221K sold.

Cetera Advisor Networks first reported a position in AKBA in Q2 2020 and held it in 1 quarter. The position peaked at $221K in Q2 2020. 164 funds tracked by Wall St. Rank hold AKBA as of Q3 2020.

  • Cetera Advisor Networks reported no remaining Akebia Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Cetera Advisor Networks sold 16,292 Akebia Therapeutics shares in Q3 2020, an estimated $221K.
  • Cetera Advisor Networks first reported a position in Akebia Therapeutics in Q2 2020 and held it in 1 quarter.
  • Cetera Advisor Networks's Akebia Therapeutics position peaked at $221K in Q2 2020.
  • 164 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2020.

Based on Cetera Advisor Networks's 13F filing for Q3 2020, filed 13 Nov 2020.